Efficacy of esomeprazole in treating acid-related diseases in Japanese populations
Mitsushige Sugimoto1, Takahisa Furuta21First Department of Medicine, 2Center for Clinical Research, Hamamatsu University School of Medicine, Shizuoka, JapanAbstract: Esomeprazole (Nexium®; AstraZeneca), the S-isomer of omeprazole, is the first proton pump inhibitor (PPI) to be developed...
Main Authors: | Furuta T, Sugimoto M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-05-01
|
Series: | Clinical and Experimental Gastroenterology |
Online Access: | http://www.dovepress.com/efficacy-of-esomeprazole-in-treating-acid-related-diseases-in-japanese-a9901 |
Similar Items
-
Clinical and pharmacoeconomic profile of esomeprazole in acid-related diseases
by: Orietta Zaniolo
Published: (2006-09-01) -
Efficacy of esomeprazole at treatment of patients with gastroesophageal reflux disease
by: Yu. V. Yevsyutina
Published: (2018-08-01) -
Population pharmacokinetic modelling for dose optimization of esomeprazole to treat early-onset preeclampsia
by: Semere, Gebreyesus Manna
Published: (2021) -
Evaluation of CYP2C19 Gene Polymorphisms in Patients with Acid Peptic Disorders Treated with Esomeprazole
by: Díaz-Ordóñez L, et al.
Published: (2021-04-01) -
The influence of demographic factors and health-related quality of life on treatment satisfaction in patients with gastroesophageal reflux disease treated with esomeprazole
by: El-Dika Samer, et al.
Published: (2005-01-01)